Research programme: monoclonal antibody immunoconjugates - ImmunGene

Drug Profile

Research programme: monoclonal antibody immunoconjugates - ImmunGene

Alternative Names: IGN 004; IGN 005; IGN 006; mAb-IFN fusion proteins - ImmunGene; mAB-IFN therapeutics - ImmunGene; Monoclonal antibody fusion proteins - ImmunGene

Latest Information Update: 13 Jan 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ImmunGene
  • Class Chemokines; Cytokines; Immunoconjugates; Interferons; Monoclonal antibodies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Acute myeloid leukaemia; Cancer; Malignant melanoma; Solid tumours

Most Recent Events

  • 09 Jan 2015 Early research is ongoing in the US
  • 10 Jun 2013 Early research in Acute myeloid leukaemia in USA (Parenteral)
  • 10 Jun 2013 Early research in Malignant melanoma in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top